The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for ...

Kennedy's move appears to shortcut the CDC's outside vaccine advisers, dropping COVID vaccines from the list recommended for children and pregnant women.

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a live, weakened form of the virus to trigger immunity.

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...

The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...

May 21 (Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya ... of the CDC. Sign up here.